KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Treasury Shares: 2010-2024

Historic Treasury Shares for Pacira BioSciences (PCRX) over the last 9 years, with Dec 2024 value amounting to $837,240.

  • Pacira BioSciences' Treasury Shares rose 399.75% to $125.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.5 million, marking a year-over-year increase of 399.75%. This contributed to the annual value of $25.1 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Pacira BioSciences reported Treasury Shares of $25.1 million as of FY2024, which was up 1,255,950.00% from $2,000 recorded in FY2012.
  • Over the past 5 years, Pacira BioSciences' Treasury Shares peaked at $25.1 million during FY2024, and registered a low of $25.1 million during FY2024.
  • Moreover, its 1-year median value for Treasury Shares was $837,240 (2024), whereas its average is $837,240.
  • Data for Pacira BioSciences' Treasury Shares shows a peak YoY surged of 51.70% (in 2020) over the last 5 years.
  • Yearly analysis of 2 years shows Pacira BioSciences' Treasury Shares stood at $957,453 in 2020, then followed by $837,240 in 2024.